Product

177Lu-LNC1004 Injection

Aliases

177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004 Injection group 3 radionuclide therapy, 177Lu-LNC1004 Injection group 4 radionuclide therapy

1 clinical trial

3 indications

Indication

Solid Tumor

Indication

Unspecified

Indication

Adult

Clinical trial

Phase I, Open-Label Study of the Safety and Dosimetry of a 4-Dose Regimen of Escalating Doses of 177Lu-LNC1004 Injection in Adult Patients With Advanced Fibroblast Activation Protein (FAP)-Positive Solid Tumors

Status: Recruiting, Estimated PCD: 2025-03-10